CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Sees Significant Increase in Short Interest

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 1,490,000 shares, a growth of 15.5% from the July 15th total of 1,290,000 shares. Approximately 15.4% of the shares of the company are short sold. Based on an average daily trading volume, of 4,530,000 shares, the days-to-cover ratio is currently 0.3 days.

CERo Therapeutics Stock Performance

NASDAQ CERO remained flat at $0.15 on Friday. 1,365,015 shares of the company traded hands, compared to its average volume of 7,944,116. CERo Therapeutics has a 1-year low of $0.12 and a 1-year high of $12.80. The company’s fifty day simple moving average is $0.26.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.